EPS for Check-Cap Ltd. (CHEK) Expected At $-0.14; Bay Bancorp (BYBK)’s Sentiment Is 1.36

February 11, 2018 - By Michael Collier

Analysts expect Check-Cap Ltd. (NASDAQ:CHEK) to report $-0.14 EPS on March, 8.They anticipate $0.01 EPS change or 6.67% from last quarter’s $-0.15 EPS. After having $-0.13 EPS previously, Check-Cap Ltd.’s analysts see 7.69% EPS growth. The stock decreased 8.33% or $0.06 during the last trading session, reaching $0.66. About 147,664 shares traded. Check-Cap Ltd. (NASDAQ:CHEK) has declined 2.26% since February 11, 2017 and is downtrending. It has underperformed by 18.96% the S&P500.

Bay Bancorp, Inc. operates as a bank holding firm for Bay Bank, FSB that provides banking services and products to small and medium-sized commercial and retail businesses, business professionals, and individual clients in the central Maryland region. The company has market cap of $131.30 million. The Company’s deposit products include demand, money market, and savings accounts, as well as time deposits; and certificate of deposit registry service and insured cash sweep deposits. It has a 27.22 P/E ratio. The companyÂ’s loan portfolio comprises commercial loans, such as lines of credit, revolving credit facilities, accounts receivable and inventory financing, term loans, equipment loans, small business administration loans, stand-by letters of credit, and unsecured loans; commercial and residential real estate loans; loans for land acquisition, land development, and/or construction of residential or commercial structures; home equity line of credit; and consumer and other loans, such as installment loans, personal lines of credit, and automobile loans.




Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap had 11 analyst reports since July 22, 2015 according to SRatingsIntel. Chardan Capital Markets maintained Check-Cap Ltd. (NASDAQ:CHEK) on Wednesday, March 16 with “Buy” rating. As per Wednesday, July 22, the company rating was maintained by Chardan Capital Markets. The rating was initiated by Maxim Group with “Buy” on Thursday, October 8. Maxim Group maintained Check-Cap Ltd. (NASDAQ:CHEK) rating on Tuesday, January 19. Maxim Group has “Buy” rating and $11.0 target. The rating was maintained by Chardan Capital Markets on Friday, May 20 with “Buy”. Maxim Group maintained the stock with “Buy” rating in Tuesday, May 30 report. H.C. Wainwright maintained Check-Cap Ltd. (NASDAQ:CHEK) on Thursday, January 11 with “Buy” rating. The firm has “Buy” rating given on Thursday, January 19 by Rodman & Renshaw. H.C. Wainwright maintained Check-Cap Ltd. (NASDAQ:CHEK) on Thursday, September 28 with “Buy” rating. H.C. Wainwright maintained the stock with “Buy” rating in Friday, August 11 report.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $12.72 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.